$RXMD News: Progressive Care Inc. Speaks About Alt
Post# of 1525
(Total Views: 192)
Posted On: 02/04/2019 8:15:46 AM
$
RXMD
News: Progressive Care Inc. Speaks About Alternative Medicine to Combat the Opioid Crisis
Company Secured Media Coverage in Insider Financial and Cannabis Radio Show
MIAMI, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Insider Financial and Cannabis Radio Show as one of the top plays for investors looking to make money off the opioid crisis in the U.S. and using alternative medicine to combat the crisis.
“I am honored to be recognized in Insider Financial and Cannabis Talk A to Z regarding the opioid crisis, something I am so passionate about fighting,” said S. Parikh Mars, CEO of Progressive Care Inc. “Progressive Care strives to put patients first by offering the best alternatives to opioid medications and by making the process to attain these medicines seamless and affordable.”
In an article titled Progressive Care Inc (RXMD): A Top Play on Opioid Crisis, published on January 14, 2019, Insider Financial discussed how Progressive Care is in an ongoing fight for non-opioid treatments for pain to be routinely covered by insurance. Today, insurance companies are restricting benefits to the point where a patient can no longer get coverage for outpatient pain management solutions other than prescription grade ibuprofen, or Tylenol.
In the radio show titled Cannabis Talk A to Z with Guest Shital Mars, Mars discussed how there are other treatments available to address pain, one with the most potential and importance being CBD, however doctors and pharmacies alike are not providing their patients with any guidance on proper dosage or methods making patients seek is out themselves. Mars and Progressive Care believes that the end goal is for medical marijuana, both THC and CBD, to be provided by a pharmacy and health care providers so that patients can safely use cannabis to address their needs in combination with their other prescribed medications.
The recent media coverage comes after the company’s efforts to provide its network with more healthcare informational resources through PharmCo Pharmacy. Additional commentary from Progressive Care’s CEO about the company and industry as a whole can be found on the Progressive Care blog and PharmCo blog.
For more immediate updates on the company’s media coverage, connect with Progressive Care and PharmCo on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Company Secured Media Coverage in Insider Financial and Cannabis Radio Show
MIAMI, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Insider Financial and Cannabis Radio Show as one of the top plays for investors looking to make money off the opioid crisis in the U.S. and using alternative medicine to combat the crisis.
“I am honored to be recognized in Insider Financial and Cannabis Talk A to Z regarding the opioid crisis, something I am so passionate about fighting,” said S. Parikh Mars, CEO of Progressive Care Inc. “Progressive Care strives to put patients first by offering the best alternatives to opioid medications and by making the process to attain these medicines seamless and affordable.”
In an article titled Progressive Care Inc (RXMD): A Top Play on Opioid Crisis, published on January 14, 2019, Insider Financial discussed how Progressive Care is in an ongoing fight for non-opioid treatments for pain to be routinely covered by insurance. Today, insurance companies are restricting benefits to the point where a patient can no longer get coverage for outpatient pain management solutions other than prescription grade ibuprofen, or Tylenol.
In the radio show titled Cannabis Talk A to Z with Guest Shital Mars, Mars discussed how there are other treatments available to address pain, one with the most potential and importance being CBD, however doctors and pharmacies alike are not providing their patients with any guidance on proper dosage or methods making patients seek is out themselves. Mars and Progressive Care believes that the end goal is for medical marijuana, both THC and CBD, to be provided by a pharmacy and health care providers so that patients can safely use cannabis to address their needs in combination with their other prescribed medications.
The recent media coverage comes after the company’s efforts to provide its network with more healthcare informational resources through PharmCo Pharmacy. Additional commentary from Progressive Care’s CEO about the company and industry as a whole can be found on the Progressive Care blog and PharmCo blog.
For more immediate updates on the company’s media coverage, connect with Progressive Care and PharmCo on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
(1)
(0)Progressive Care Inc. (RXMD) Stock Research Links
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
Scroll down for more posts ▼